about
Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem).Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation?The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment.Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.β1-Adrenergic Receptor Contains Multiple IAk and IEk Binding Epitopes That Induce T Cell Responses with Varying Degrees of Autoimmune Myocarditis in A/J Mice.Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion.Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.Thyroid Autoantibodies Display both “Original Antigenic Sin” and Epitope Spreading.Biomarkers related to bullous pemphigoid activity and outcome.Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque.Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases.New insights into pemphigoid diseases.Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid.A New Classification System for IgG4 Autoantibodies.Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity.Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.Targeting B Cells and Plasma Cells in Autoimmune Diseases.Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic ReviewA Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair HypoplasiaGlycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid DisordersThe Growing Incidence of Bullous Pemphigoid: Overview and Potential ExplanationsMeta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patientsImmunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal MiceInteraction of Psoriasis and Bullous DiseasesLoss of Smad7 Promotes Inflammation in Rheumatoid Arthritis
P2860
Q38601424-FC6E6DC4-1798-4066-8253-9EBAF0E71D28Q41453337-A1A69A68-AA3D-4203-B0D7-495B5C755C1DQ41684146-68BF367E-56F2-4351-A41F-4DF159D8842EQ46244253-6F42F5BE-C1D9-4B2A-A50A-FC840B2108EEQ47117298-1A9E6522-94BA-42EE-B77F-ED3D812BF6F8Q47139654-854ADCAA-D62E-4461-B457-71ACF4F64F11Q47180614-A7758BC1-83A2-4284-B6CF-4A343D2B91CCQ47412579-3E25C7A6-50A7-49AA-810C-F9B2F47EC8BFQ47438953-6BDA1B08-5FD9-4045-AEDB-785FF46CBD68Q47554814-FF9F5D0E-5023-4A3D-B6F6-899FD2D4B618Q47880572-A799170D-9311-4418-9BC1-5C8D1D7833C4Q49842338-BB001FB8-6C13-4C4B-86EA-64BC88B84C20Q50074773-F0F0B05E-2234-4703-8342-99A23772BE47Q50193260-3B5848B8-7F47-4BF6-A164-21001DF709CDQ50300681-DC7979AE-8249-4484-9F7C-1AD00D6A146EQ50327901-88261F72-AA3E-4928-AF0C-ECEEB7A5F990Q50333828-82787331-AE58-4EE6-8315-C35625B2BE68Q51732392-7732D9BA-951C-4924-BF79-A209D36B41CDQ52332743-9926AD7A-9806-47B0-B1F2-E7CDD5E76EBCQ52370705-F1CE83E6-33B1-41A8-AA09-6C23E271B640Q52603631-9B65CB8D-C49A-4C04-BB86-54BBE08CC80FQ54940292-517BF6ED-5025-4274-B41F-B01E755011C5Q55100401-EBC6F4D7-D06E-4127-9795-9789864055C8Q55102352-D40D711B-15FA-4CB4-993C-ACED0E60AFA2Q55196540-2B460BF0-14C2-4642-AA7C-337F5E3864F3Q55224884-35385505-885E-4378-A0FD-E980FA3A8488Q55234556-2D26F5AC-2131-4AD4-A107-29742F8F4A15Q55489605-41F3B6DD-7C53-4E7A-A22E-4E09FC5F8B1BQ57538743-137DBB69-4EBF-4433-A3B9-852BA252E406Q58556238-152369E7-5E84-4B9D-9EF4-298210A5212DQ58730241-69346E59-5862-432C-8ECD-C255B55DB021Q58735688-26AB1D36-7077-4F82-8A25-12ACC37B219DQ58765602-4159A54B-0464-4C6E-B061-24673FBA93BDQ58767171-BA59825A-5A05-432F-8815-DAC7E996482CQ58795480-A1B80BA8-BB96-4A23-A5B4-BBEF647D1392Q59132126-BAA8E2C2-11BD-4717-B2CC-2A3CA6FFB060
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Mechanisms of Autoantibody-Induced Pathology.
@ast
Mechanisms of Autoantibody-Induced Pathology.
@en
type
label
Mechanisms of Autoantibody-Induced Pathology.
@ast
Mechanisms of Autoantibody-Induced Pathology.
@en
prefLabel
Mechanisms of Autoantibody-Induced Pathology.
@ast
Mechanisms of Autoantibody-Induced Pathology.
@en
P2093
P2860
P50
P356
P1476
Mechanisms of Autoantibody-Induced Pathology
@en
P2093
Alan Verkman
Andrea Fischer
Asmaa El Beidaq
Basil Rapoport
Christian Probst
Christoph M Hammers
Falk Nimmerjahn
Frank Leypoldt
Gabriela Riemekasten
P2860
P356
10.3389/FIMMU.2017.00603
P577
2017-05-31T00:00:00Z